Caricamento...
Systemic therapy for patients with advanced, unresectable ormetastatic renal cell carcinoma: moving to guidelines
Until recently, patients with advanced, unresectable or metastatic renal cell cancer (RCC) had very few therapeutic options. Cytokine therapy, consisting mainly of interferon-α and interleukin-2, was considered the mainstay of therapy. A better understanding of the biology of RCC has led to the deve...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Canadian Medical Association
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2422947/ https://ncbi.nlm.nih.gov/pubmed/18542783 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|